CDKN2A and neoplasm: p16INK4A acts as a tumor- suppressor by binding to CDK4/6 and thus restrict the cell cycle to enter the G1/S phase by cutting off interaction of CDK4/6 and cyclin D1, and later phosphorylation process of retinoblastoma protein (RB1) [7].